Lexicon Pharmaceuticals (LXRX) Metrics: History & Chart

Lexicon Pharmaceuticals, Inc.(LXRX)

Biotechnology · The Woodlands, TX

$1.75+0.01 (+0.66%)

Delayed quote: Oct 6, 2026, 11:05 AM EDT

About Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the end-to-end process of identifying, advancing, and bringing to market novel therapeutic compounds. Its development pipeline includes orally administered small molecule drug candidates such as Sotagliflozin, which has successfully concluded Phase III clinical studies for treating both heart failure and type 1 diabetes, and LX9211, currently undergoing Phase II clinical development for neuropathic pain. The firm maintains important strategic collaborations and licensing arrangements with pharmaceutical industry leaders, including Bristol-Myers Squibb Company and Genentech, Inc. Established in 1995, Lexicon Pharmaceuticals, Inc. is based in The Woodlands, Texas.

The Woodlands, TX

81 employees

www.lexpharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Michael S. Exton

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-8.42%
30D Total Return	-22.32%
YTD Total Return	+51.30%
1Y Total Return	+23.40%
3Y Total Return	+65.71%
5Y Total Return	-64.13%
10Y Total Return	-90.56%
15Y Total Return	-74.39%
20Y Total Return	-93.61%

2026	+51.30%
2025	+55.72%
2024	-51.73%
2023	-19.90%
2022	-51.52%
2021	+15.20%
2020

CAGR TTM	+23.28%
CAGR 3Y	+18.33%
CAGR 5Y	-18.54%
CAGR 10Y	-21.03%
CAGR 15Y	-8.68%
CAGR 20Y	-12.85%

PE Ratio	13.17
PE Ratio Avg TTM	12.73
PE Ratio Avg 3Y	5.97
Current VS TTM Avg	+3.49%
Current VS 3Y Avg	+120.58%
Current VS 5Y Avg	+120.58%

All Metrics

LXRX Valuation Metrics

LXRX Stock Price Metrics

LXRX Dividend Metrics

LXRX Growth Rate Metrics

LXRX Discounted Cash Flow Metrics

LXRX Returns By Period

LXRX Yearly Returns

LXRX Average Annual Returns By Period (CAGR)

LXRX Revenue Metrics

LXRX PE Ratio Metrics

LXRX PS Ratio Metrics

LXRX PB Ratio Metrics

LXRX Price to Free Cash Flow Ratio Metrics

LXRX Debt to Equity Ratio Metrics

LXRX PEG Ratio Metrics

LXRX FCF Yield

LXRX Earnings Yield

LXRX EBITDA Yield

LXRX OCF Yield

LXRX EV/EBIT Ratio Metrics

LXRX EV/EBITDA Ratio Metrics

LXRX EV/Assets Ratio Metrics

LXRX EV/Sales Ratio Metrics

LXRX Current Ratio Metrics

LXRX Quick Ratio Metrics

LXRX ROIC Metrics

LXRX Return on Assets Metrics

LXRX Return on Equity Metrics

LXRX Net Profit Margin Metrics

LXRX Gross Profit Margin Metrics

LXRX Tax Rate Metrics

PS Ratio	18.36
PS Ratio Avg TTM	10.75
PS Ratio Avg 3Y	62.05
Current VS TTM Avg	+70.79%
Current VS 3Y Avg	-70.41%
Current VS 5Y Avg	-96.25%

PB Ratio	4.36
PB Ratio Avg TTM	4.64
PB Ratio Avg 3Y	3.11
Current VS TTM Avg	-6.01%
Current VS 3Y Avg	+40.41%
Current VS 5Y Avg	+28.11%

PFCF Ratio	1.21
PFCF Ratio Avg TTM	2.47
PFCF Ratio Avg 3Y	2.47
Current VS TTM Avg	-50.96%
Current VS 3Y Avg	-50.96%
Current VS 5Y Avg	-81.10%

Debt/Equity Ratio	0.34
Debt/Equity Ratio Avg TTM	0.44
Debt/Equity Ratio Avg 3Y	0.59
Current VS TTM Avg	-23.44%
Current VS 3Y Avg	-42.59%
Current VS 5Y Avg	-22.09%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	82.44%
FCF Yield Avg TTM	46.69%
FCF Yield Avg 3Y	46.69%
Current VS TTM Avg	+76.58%
Current VS 3Y Avg	+76.58%
Current VS 5Y Avg	+191.19%

Earnings Yield	7.60%
Earnings Yield Avg TTM	7.77%
Earnings Yield Avg 3Y	26.87%
Current VS TTM Avg	-2.22%
Current VS 3Y Avg	-71.71%
Current VS 5Y Avg	-71.71%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	16.21
Ev/Ebit Ratio Avg TTM	15.61
Ev/Ebit Ratio Avg 3Y	4.56
Current VS TTM Avg	+3.88%
Current VS 3Y Avg	+255.82%
Current VS 5Y Avg	+255.82%

Ev/Ebitda Ratio	15.30
Ev/Ebitda Ratio Avg TTM	14.73
Ev/Ebitda Ratio Avg 3Y	4.34
Current VS TTM Avg	+3.88%
Current VS 3Y Avg	+252.15%
Current VS 5Y Avg	+252.15%

Ev/Assets Ratio	3.12
Ev/Assets Ratio Avg TTM	3.08
Ev/Assets Ratio Avg 3Y	1.98
Current VS TTM Avg	+1.23%
Current VS 3Y Avg	+57.73%
Current VS 5Y Avg	+42.71%

Ev/Sales Ratio	18.81
Ev/Sales Ratio Avg TTM	11.12
Ev/Sales Ratio Avg 3Y	63.27
Current VS TTM Avg	+69.20%
Current VS 3Y Avg	-70.27%
Current VS 5Y Avg	-95.29%

Current Ratio	13.37
Current Ratio Avg TTM	9.37
Current Ratio Avg 3Y	8.59
Current VS TTM Avg	+42.66%
Current VS 3Y Avg	+55.60%
Current VS 5Y Avg	+133.94%

Quick Ratio	13.29
Quick Ratio Avg TTM	9.34
Quick Ratio Avg 3Y	8.57
Current VS TTM Avg	+42.20%
Current VS 3Y Avg	+54.97%
Current VS 5Y Avg	+132.74%

ROIC	(23.16%)
ROIC Avg 3Y	(52.90%)
ROIC Avg 5Y	(58.84%)
Current VS 3Y Avg	+56.22%
Current VS 5Y Avg	+60.65%
Current VS 10Y Avg	+52.12%

ROA	(24.44%)
ROA Avg TTM	(5.25%)
ROA Avg 3Y	(12.31%)
Current VS TTM Avg	-365.54%
Current VS 3Y Avg	-98.52%
Current VS 5Y Avg	-76.44%

ROE	(35.02%)
ROE Avg TTM	(48.99%)
ROE Avg 3Y	(90.18%)
Current VS TTM Avg	+28.52%
Current VS 3Y Avg	+61.17%
Current VS 5Y Avg	+58.81%

Net Profit Margin	(147.38%)
Net Profit Margin Avg TTM	(991.64%)
Net Profit Margin Avg 3Y	(2309.81%)
Current VS TTM Avg	+85.14%
Current VS 3Y Avg	+93.62%
Current VS 5Y Avg	+99.52%

Gross Profit Margin	98.85%
Gross Pft Margin Avg TTM	97.45%
Gross Pft Margin Avg 3Y	95.31%
Current VS TTM Avg	+1.44%
Current VS 3Y Avg	+3.71%
Current VS 5Y Avg	+9.02%

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	+100.00%